﻿               SEQUENCE LISTING

<110> Fondazione Istituto Italiano di Tecnologia
      Fondazione IRCCS Istituto Nazionale dei Tumori
      Consiglio Nazionale delle Ricerche
      Universidade de Santiago de Compostela
      Università degli Studi di Genova

<120> Magnetic nanoparticles for use in the treatment of tumors

<130> BW314F

<160> 2

<170> BiSSAP 1.3.6

<210> 1
<211> 281
<212> PRT
<213> Artificial Sequence


<220> 
<223> frammento anticorpale scFv

<400> 1
Met Lys Tyr Leu Leu Pro Thr Ala Ala Ala Gly Leu Leu Leu Leu Ala 
1               5                   10                  15      
Ala Gln Pro Ala Met Ala Asn Val Gln Leu Val Glu Ser Gly Gly Gly 
            20                  25                  30          
Leu Val Gln Pro Gly Arg Ser Leu Arg Leu Ser Cys Thr Thr Ser Gly 
        35                  40                  45              
Phe Thr Phe Gly Asp Tyr Ala Met Ile Trp Ala Arg Gln Ala Pro Gly 
    50                  55                  60                  
Lys Gly Leu Glu Trp Val Ser Ser Ile Ser Ser Ser Ser Ser Tyr Ile 
65                  70                  75                  80  
Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn 
                85                  90                  95      
Ala Lys Asn Ser Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp 
            100                 105                 110         
Thr Ala Val Tyr Tyr Cys Ala Arg Glu Arg Tyr Asp Phe Trp Ser Gly 
        115                 120                 125             
Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser Gly Gly 
    130                 135                 140                 
Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Ser Ala Gln Ser Ala Leu 
145                 150                 155                 160 
Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln Ser Ile Thr Ile 
                165                 170                 175     
Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr Asn Leu Val Ser 
            180                 185                 190         
Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu Met Ile Tyr Glu 
        195                 200                 205             
Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe Ser Gly Ser Lys 
    210                 215                 220                 
Ser Gly Asn Ala Ala Ser Leu Thr Ile Ser Gly Leu Gln Ala Glu Asp 
225                 230                 235                 240 
Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser Leu Ser Val Val 
                245                 250                 255     
Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala Ala Ala His His 
            260                 265                 270         
His His His His Gly Ala Ala Glu Gln 
        275                 280     

<210> 2
<211> 843
<212> DNA
<213> Artificial Sequence


<220> 
<223> DNA codificante per frammento scFv C4

<400> 2
atgaaatacc tattgcctac ggcagccgct ggattgttat tactcgcggc ccagccggcc      60

atggccaacg tgcagctggt ggagtctggg ggaggcttgg tacagccagg gcggtccctg     120

agactctcct gcacaacttc tggattcact tttggtgatt atgctatgat ctgggcccgc     180

caggctccag ggaaggggct ggagtgggtc tcatccatta gtagtagtag tagttacata     240

tactacgcag actcagtgaa gggccgattc accatctcca gagacaacgc caagaactca     300

ctgtatctgc aaatgaacag cctgagagcc gaggacacgg ctgtgtatta ctgtgcgaga     360

gaacgatacg atttttggag tggaatggac gtctggggca aagggaccac ggtcaccgtc     420

tcgagtggtg gaggcggttc aggcggaggt ggctctggcg gtagtgcaca gtctgccctg     480

actcagcctg cctccgtgtc tgggtctcct ggacagtcga tcaccatctc ctgcactgga     540

accagcagtg atgttgggag ttataacctt gtctcctggt accaacagca cccaggcaaa     600

gcccccaaac tcatgattta tgagggcagt aagcggccct caggggtttc taatcgcttc     660

tctggctcca agtctggcaa cgcggcctcc ctgacaatct ctgggctcca ggctgaggac     720

gaggctgatt attactgcca gtcctatgac agcagcctga gtgtggtatt cggcggaggg     780

accaagctga ccgtcctagg tgcggccgca catcatcatc accatcacgg ggccgcagaa     840

caa                                                                   843


